menzies
Guru
First I have seen trial data presented in this way, though I may have missed others.
From phase 1/2 JNJ trials and showing timing and percentage of participants with the antibodies, and of them staying in the body - so far for the length of the trial.
(Disclosure; JNJ retiree).
https://finance.yahoo.com/m/27cec707-f9d8-3c12-a273-0bf6a0aa7b75/j-j-s-covid-19-vaccine.html
From phase 1/2 JNJ trials and showing timing and percentage of participants with the antibodies, and of them staying in the body - so far for the length of the trial.
(Disclosure; JNJ retiree).
https://finance.yahoo.com/m/27cec707-f9d8-3c12-a273-0bf6a0aa7b75/j-j-s-covid-19-vaccine.html